TrialBMC musculoskeletal disorders2017

Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis.

Makoto Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.